Haider Inam (@HaiderInam) header
Haider Inam (@HaiderInam) profile picture

Research Scientist at the Broad Institute of MIT and Harvard

Cambridge, MA
Joined February 2010
Acquired drug resistance is a major barrier to curative cancer therapies. I'm excited to share our new study describing a gene therapy platform that proactively targets resistance and enables durable remissions. Out now in @NatureBiotech 🧵below
Programming tumor evolution with selection gene drives to proactively combat drug resistance go.nature.com/4bLLeFb
4
5
16
7,062
Haider Inam retweeted
Haider Inam on quantifying resistance to targeted anticancer therapies at scale with duplex sequencing #VariantEffect23
4
1
15
2,374
Next up is @ScottLeighow from @JustinPritcha19 lab presenting: Design and construction of evolutionary-guided “selection gene drive” therapy #AACRevol22 Very cool talk!
Haider Inam retweeted
Pairwise tests for conditional selection use evolutionary logic to predict intrinsic drug resistance in ALK alterations dlvr.it/R85PZr
1
1